Open in interactive viewer → charts, metric popovers & call review

Parsons Has a $12 Billion Waiting Room — and a Revenue Problem

Record bookings, record margins, record cash — and a narrowed sales guide with flat organic growth. The gap between what Parsons wins and what it bills is now the whole story.
PSN · Earnings Call · 2026-10-28

The bid-to-book gap

Parsons did everything right except grow. Q3 total revenue rose 2% but fell 1% organically; excluding the confidential contract that is winding down, it grew 2% organically. Against that, contract awards rose 14% to $1.8 billion, Federal awards jumped 53% year-over-year, book-to-bill was 1.1x for the quarter and 1.2x year-to-date, total backlog hit a record $9.4 billion (73% funded, a record $6.8 billion) and $12 billion of contracts are awarded but not yet booked. And yet the guidance was narrowed, not raised: $6.25–$6.45 billion of revenue and $510–$515 million of adjusted EBITDA. A $6.35 billion midpoint sits barely above the roughly $6.30 billion Parsons booked in 2025.Revenue has stalled near $1.6 billion a quarter for six straight quarters. Carey Smith frames it as conversion, not demand: “The goal now is really how quickly we can convert those awards into revenue, and that's where we're laser-focused.” — Carey Smith, Chair, President and Chief Executive Officer · 2026-10-28 Fair — but this is the third consecutive quarter of the same sentence. In July, Gavin Parsons of UBS put the pattern bluntly: “bookings have been pretty strong for a while, but you've had to cut revenue guide a couple of times in the last year or 2.” — Gavin Parsons, Analyst · 2026-07-29 Carey's answer then was that the revision was “about portfolio composition and timing. It has nothing to do with demand.” — Carey Smith, Chair, President and CEO · 2026-07-29 Three months later the composition is cleaner, the demand is still there, and the timing hasn't improved.

I have high confidence in the midpoint and really just want to get back to that beat mode.

Matt Ofilos, Chief Financial Officer · 2026-10-28
That is the tell. This is a management team that has stopped trying to be clever with guidance and is instead sandbagging the fourth quarter after a record Q3 — and Matt Ofilos, the CFO who took the market through both guide-downs, is stepping down effective November 6, with former CFO and board member George Ball returning as interim. Nothing about the quarter was broken. Everything about the setup is unresolved.

Record margins with an asterisk

The 10.2% adjusted EBITDA margin was a company record, and Critical Infrastructure cleared 11% for the first time at 11.1%. But the margin expansion is partly arithmetic. Matt Ofilos was candid that lower pass-through volumes — materials and ODCs booked at almost no margin — flattered the rate: “the pass-through dollars, while it looks a little bit worse on the revenue side, it does benefit the EBITDA dollars and margin rate.” — Matt Ofilos, Chief Financial Officer · 2026-10-28 The same dynamic appeared in Q2, where roughly half the revenue reduction was pass-through. So the company is printing records by mixing out of low-margin revenue while the high-margin work it has won keeps sitting in the awarded-not-booked bucket. It is a real quality improvement, but it is not growth, and the Q2 operating margin of 0.2% shows what one bad estimate revision does to this P&L.

The number that actually changed: products

Buried in the Q&A was a disclosure Parsons had never quantified before — analyst Jonathan Siegmann thanked management for "qualifying product revenue base today." Henceforth the company has a $350 million annual products-and-related-services business, guided to grow 20–30% in 2027 at margins north of 20%, roughly double the Federal segment's run rate. Ofilos did the math out loud: “if you think about products as a whole 2x what let's call it kind of high 9 or mid- to high 9 that Fed should be -- that's probably a good target.” — Matt Ofilos, Chief Financial Officer · 2026-10-28 The flagship is the Joint Cyber Hunt Kit, whose ceiling value with U.S. Cyber Command was lifted to $750 million over five years, with roughly 74 kits a year for three years and $250 million booked to date. Around it: 26 other transaction agreements worth $1.6 billion in aggregate ceiling, a ~$2 billion OTA pipeline, a new classified biometrics and identity management contract, and the Space Command headquarters award at Redstone. The peer group is converging on the same language — Booz Allen spent its call on defense tech products and outcome based contracting — which makes this a sector rotation out of cost-plus bodies and into hardware and software, not a Parsons idiosyncrasy. The honest caveat: $350 million is about 5.5% of revenue. Growing it 25% adds roughly $90 million, or 1.4 points of top line. For now products are a margin story dressed as a growth story, and the market will want evidence that the OTA ceilings actually convert before it re-rates the multiple.

What slipped, and what management stopped saying

Two quiet admissions matter more than the headlines. First, the Middle East — 65% of which is Saudi Arabia — decelerated: “there was some slow in Saudi, which makes up 65 % of our Middle East business and that was due to a rephasing of programs by the public investment funds.” — Carey Smith, Chair, President and Chief Executive Officer · 2026-10-28 Middle East book-to-bill of 0.8x is the blemish on the 24-consecutive-quarter streak. Second, the Canadian joint venture has slipped again. In July Carey said “It will be 90 % done at the end of this year.” — Carey Smith, Chair, President and CEO · 2026-07-29 On this call: “the project is over 75 % complete as of today.” — Carey Smith, Chair, President and Chief Executive Officer · 2026-10-28 Resequencing around historic rainfall is defensible; a 10-point schedule slide in one quarter, on a fixed-price consortium where Parsons is the non-managing partner, is exactly the kind of thing that produced the $118 million charge. Management assumes no Q4 charge. Completion is now June 2028. Look, too, at what dropped out of the narrative. The portfolio shaping theme that dominated the July call — the SETA divestiture, the Intelligence Community conflict of interest, the remote-location exit — is gone from the top of this transcript, with divestiture momentum collapsing quarter-over-quarter. That work is largely done and, to be fair, the remote-location sale was the right call. But it means the 2027 story has no more self-help cuts to lean on, only the conversion of the $12 billion.

The valuation is the argument

The stock sits 55% below its November 2024 peak of $113.31 and 19% below its July high of $62.03, and has gone nowhere over 90 days. Parsons is now priced at 0.5x revenue, down 58% year-over-year from 1.1x. Against that, Q3 operating cash flow was $269 million versus $163 million a year earlier, trailing-twelve-month free cash flow conversion was 130%, and the company bought back $60 million of stock in the quarter, $110 million year-to-date, up nearly 70%. Ofilos said it plainly: “We have increased share repurchases given our view that the current stock price does not fully reflect Parsons' long-term value.” — Matt Ofilos, Chief Financial Officer · 2026-10-28 Leverage is a manageable 2.1x, though effective net cash of -$1.2 billion shows how much of the balance sheet went into buying capability rather than building it. The bull case at 0.5x sales is not complicated: keep 1.1x book-to-bill, clear the $850 million of protests, convert products at 20%+ margins, and the math takes care of itself. The bear case is the last six quarters: it hasn't yet. Carey gave the required hedge — “we are going to be cautious that some of the macro headwinds that we experienced in 2026 could persist into 2027.” — Carey Smith, Chair, President and Chief Executive Officer · 2026-10-28 — under the cloud of a geopolitical uncertainty line item that now trumps even the continuing resolution he says Parsons can "run under" for a long time. What investors are really being asked to buy is a specific claim: that the ~$19 billion of proposals submitted this year, the 109 pipeline opportunities above $100 million, and a $1.6 billion OTA book finally turn into billings in 2027. Guidance in February, with a new CFO on the call, will be the first honest test of whether disciplined execution means winning work or billing it.